COPN Cosmo N.V.
Partial data58.20CHF+2.28%Mkt Cap: 1.15B $P/E: —48d ago
Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-ass…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap1.15B USD
Enterprise Value942.04M USD
Revenue (TTM)117.20M USD
Gross Profit57.70M USD
Net Income (TTM)-4.12M USD
Revenue/Share6.22 CHF
Last Price58.20 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees365
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINNL0011832936
Valuation
P/E (Trailing)—
P/E (Forward)17.31
PEG—
EV/EBITDA685.56
EV/Revenue8.04
P/S9.83
P/B1.90
EPS (TTM)-0.35
EPS (Forward)3.39
52W Range
56.5031% of range62.00
52W High62.00 CHF
52W Low56.50 CHF
Profitability
Gross Margin48.53%
Oper. Margin-17.73%
EBITDA Margin1.17%
Profit Margin-3.46%
ROE-0.75%
ROA-0.59%
Growth
Revenue Growth-2.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.25M USD
CapEx (TTM)6.23M USD
FCF Margin-26.44%
FCF Yield-2.69%
Net Debt-217.26M USD
Net Debt/EBITDA-158.11
Balance Sheet
Debt/Equity0.01
Current Ratio10.66
Quick Ratio9.84
Book Value/Sh30.94 CHF
Cash/Share11.32 CHF
Dividends
Fwd Div Rate1.92 CHF
Trail. Div Rate2.10 CHF
Div. Yield3.27%
5Y Avg Yield—
Payout Ratio113.48%
Ex-Div DateApr 24, 2026
Pay DateJun 6, 2025
Analyst Consensus
Rating—
Target (Mean)122.58 CHF
Upside (mean)+110.6%
Target Range92.60 CHF – 163.23 CHF
92.60+110.6% to mean163.23
# Analysts5
Ownership
Shares Out.17.19M
Float9.69M
Insiders51.77%
Institutions18.94%
Technical
SMA 5064.01 (-9.1%)
SMA 20085.05 (-31.6%)
Beta1.48
S&P 52W Chg18.16%
Avg Vol (30d)26.49K
Avg Vol (10d)20.92K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—